The identification of new molecular targets and the growth of personalized therapies for cancer depend on current studies, and it is believed that new advances in molecular science will contribute to the development of innovative and successful methods for therapy, and eventually decrease the prevalence of malignancies...
Hardha Balachandran, Gowramma Byran, S. Murugesan et al.· Current Cancer Drug Targets· 0 citations
2ANN is identified as a promising AMP candidate for further investigation against MDR P. aeruginosa, as the findings are based exclusively on computational prediction and simulation, experimental validation is required to confirm its biological activity and mechanism of action.
D. G. T. Parambi, P. Prabitha, T. Alsahli et al.· Probiotics and Antimicrobial...· 0 citations
The docking, ADMET, and MD simulation studies indicate that the designed shikimic acid derivatives have good binding affinity and drug-like properties, and are stable in the active site of the SARS-CoV-2 main protease.
Hardha Balachandran, Kaviarasan Lakshmanan, Dipen Purohit et al.· Current Computer - Aided Dru...· 0 citations
MKIs and bispecific antibodies represent transformative modalities in modern oncology, supported by robust clinical evidence and extensive patent activity.
Thirumalaikumaran Rathinam, S. Reddy, Yella Sirisha et al.· Recent Patents on Anti-Cance...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.